Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Phase Ib: To estimate the MTD and/or RP2D of MEK162 in combination with panitumumab Phase II: To assess clinical efficacy of the MEK162 and panitumumab combination
Critère d'inclusion
- Mutant RAS or wild-type (WT) RAS metastatic colorectal cancer